IFP Advisors’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALZN
HF
RA
TRCT
HIA
IFP Advisors's ALZN Position: Q4 2023 in Review
IFP Advisors sold out of Alzamend Neuro (ALZN) in Q4 2023, closing a stake of 4 shares — an estimated $1.19K sold.
IFP Advisors first reported a position in ALZN in Q4 2022 and held it in 4 quarters. The position peaked at $62.1K in Q1 2023. 14 funds tracked by Wall St. Rank hold ALZN as of Q4 2023.
- IFP Advisors reported no remaining Alzamend Neuro position as of Q4 2023 after selling out during the quarter.
- IFP Advisors sold 4 Alzamend Neuro shares in Q4 2023, an estimated $1.19K.
- IFP Advisors first reported a position in Alzamend Neuro in Q4 2022 and held it in 4 quarters.
- IFP Advisors's Alzamend Neuro position peaked at $62.1K in Q1 2023.
- 14 funds tracked by Wall St. Rank held Alzamend Neuro as of Q4 2023.
Based on IFP Advisors's 13F filing for Q4 2023, filed 9 Jan 2024.